|
Dr. Piyali Dasgupta Assistant Professor of Pharmacology, Physiology and Toxicology
Education B.S. (Chemistry), University of Delhi M.S. (Chemistry), Indian Institute of Technology Ph.D. (Cancer Biology), Jawaharlal Nehru University
Research Dr. Dasgupta’s laboratory focuses on the signaling pathways by which components of cigarette smoke, such as nicotine and benzo(a)pyrene (BaP), can function in a receptor-dependent fashion to facilitate the growth and metastasis of lung cancers. Lung cancer is the leading cause of cancer deaths among women. Recent studies indicate that female smokers have an increased risk for developing lung cancer, particularly being greater risk for adenocarcinoma.
Teaching Background Prior to her arrival at Marshall, Dr. Dasgupta completed a post-doctoral fellowship in Drug Discovery at the Moffitt Research Center in Tampa, Florida. Dasgupta also served as a post-doctoral fellow in the Department of Pathology at the prestigious College of Physicians and Surgeons at Columbia University. Dasgupta is currently a member of The New York Academy of Sciences (NYAS), The American Association of Cancer Research (AACR), and The American Association for the Advancement of Science (AAAS). Contact Info telephone: (304) 696-3612 e-mail: dasgupta@marshall.edu
|
